Top 10 Drug Interactions Every Doctor Should Know

Introduction

Drug-drug interactions (DDIs) are a significant cause of adverse drug reactions, hospital admissions, and treatment failure. In Pakistan, where polypharmacy is common, particularly in elderly patients with multiple comorbidities, awareness of key interactions is essential.

1. Warfarin + NSAIDs

Risk: Major — significantly increased bleeding risk

Mechanism: NSAIDs inhibit platelet function and cause GI mucosal damage; warfarin inhibits clotting factor synthesis

Management: Avoid combination if possible. If unavoidable, use lowest effective dose of short-acting NSAID (e.g., ibuprofen) with PPI cover. Monitor INR closely.

2. ACE Inhibitors + Potassium-Sparing Diuretics

Risk: Moderate — life-threatening hyperkalemia

Mechanism: ACE inhibitors reduce aldosterone, decreasing K+ excretion; K-sparing diuretics (spironolactone, amiloride) further impair K+ excretion

Management: Avoid combination. If necessary, use low doses, monitor serum K+ and renal function frequently.

3. Clarithromycin + Statins

Risk: Major — rhabdomyolysis

Mechanism: Clarithromycin inhibits CYP3A4, dramatically increasing statin (atorvastatin, simvastatin) levels

Management: Consider alternative macrolide (azithromycin) or hold statin during clarithromycin course. Atorvastatin dose should not exceed 20 mg/day during therapy.

4. Metformin + Contrast Media

Risk: Moderate — lactic acidosis

Mechanism: IV contrast can precipitate acute kidney injury, reducing metformin clearance

Management: Hold metformin 48 hours before elective contrast studies. Restart 48 hours post-procedure if renal function stable.

5. Digoxin + Amiodarone

Risk: Major — digoxin toxicity

Mechanism: Amiodarone reduces digoxin clearance and displaces digoxin from tissue binding sites

Management: Reduce digoxin dose by 50% when starting amiodarone. Monitor digoxin levels and for signs of toxicity (arrhythmias, GI symptoms, visual disturbances).

6. Fluoroquinolones + NSAIDs

Risk: Moderate — increased CNS toxicity, seizure risk

Mechanism: NSAIDs enhance GABA receptor antagonism of fluoroquinolones

Management: Avoid combination, particularly in elderly patients and those with seizure history. Consider alternative antibiotics.

7. Methotrexate + Trimethoprim-Sulfamethoxazole

Risk: Major — severe myelosuppression

Mechanism: Both drugs inhibit dihydrofolate reductase, causing additive folate depletion

Management: Avoid this combination. If unavoidable, use with extreme caution, monitor CBC closely, and supplement with folinic acid.

8. SSRIs + MAOIs

Risk: Major — serotonin syndrome (hyperthermia, rigidity, autonomic instability)

Mechanism: Additive serotonin excess

Management: Absolute contraindication. Requires 14-day washout when switching between classes.

9. Theophylline + Ciprofloxacin

Risk: Major — theophylline toxicity (seizures, arrhythmias)

Mechanism: Ciprofloxacin inhibits CYP1A2, reducing theophylline clearance by 30-50%

Management: Reduce theophylline dose by 30-50% when starting ciprofloxacin. Monitor theophylline levels.

10. Clopidogrel + Omeprazole

Risk: Moderate — reduced clopidogrel efficacy

Mechanism: Omeprazole inhibits CYP2C19, reducing conversion of clopidogrel to its active metabolite

Management: Use pantoprazole or famotidine instead of omeprazole for acid suppression in patients on clopidogrel.

General Principles for Avoiding Interactions

1. Take a complete medication history including OTC drugs and herbal supplements
2. Verify interactions against an up-to-date, authoritative clinical resource rather than a single remembered list
3. Be aware of CYP450 enzyme interactions — many interactions involve inhibition or induction of these enzymes
4. Monitor high-risk patients more frequently
5. Keep medication lists simple — avoid unnecessary polypharmacy
6. Educate patients about signs of adverse effects

Disclaimer: This article is for educational purposes only. Always verify interactions using up-to-date clinical resources.